PE-22-28 10mg

$59.99

(5.0) (20 customer reviews)

Researched Benefits:

  • Rapidly alleviates depressive-like symptoms via TREK-1 inhibition
  • Promotes hippocampal neurogenesis and synaptogenesis
  • Reduces stroke-induced motor and cognitive deficits
  • Provides neuroprotection by minimizing neuronal apoptosis

Quantity:

Free Shipping
Buy Peptides with confidence: Stripe-powered secure checkout and major cards accepted.
Secure payment methods for buying peptides: Visa, MasterCard, AMEX, and more.
Buy Peptides with confidence: Stripe-powered secure checkout and major cards accepted.
Secure payment methods for buying peptides: Visa, MasterCard, AMEX, and more.

FREE Shipping on 

orders over $200

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.

Description

PE-22-28 10mg is a potent, short-chain research peptide (7 amino acids) derived from the spadin sequence and recognized for its high-affinity inhibition of the TREK-1 potassium channel. Manufactured from premium raw materials with state-of-the-art synthesis techniques, our PE-22-28 offers exceptional purity and stability, supporting rigorous neurological and psychiatric research applications.

Key Features:

  • ≥95 % purity verified through rigorous HPLC analysis

  • Consistent batch-to-batch quality under cGMP-aligned production standards

  • Supplied lyophilized to ensure long-term stability when stored at −20 °C

Applications:

  • Investigating rapid-onset antidepressant mechanisms and mood stabilization

  • Exploring hippocampal neurogenesis and synaptic plasticity pathways

  • Studying neuroprotection and recovery following ischemic stroke or traumatic brain injury

  • Evaluating TREK-1 channel modulation in neurodegenerative disease models

Specifications and Documentation

  • Material Safety Data Sheet (MSDS): Coming Soon.

  • Handling and Storage Instructions: Coming Soon.

PE-22-28 10 mg stands out in pre-clinical neuroscience for its capacity to induce rapid neurochemical and behavioral adaptations, making it an invaluable tool for researchers probing novel therapeutic avenues in mental health and neuroprotection.

Additional information

CAS No.

1801959-12-5

Purity

≥99%

Sequence

GVSWGLR

Molecular Formula

C35H55N11O9

Molecular Weight

773.89 g/mol

Applications

Depression models, neurogenesis studies, stroke recovery, TREK-1 inhibition

Synthesis

Solid-phase synthesis

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months.

Appearance

White lyophilized powder

Shipping Conditions

Shipped at ambient temperature; once received, store at -20°C

Regulatory/Compliance

Manufactured in a facility that adheres to cGMP guidelines

Safety Information

Refer to provided MSDS

There are no reviews yet.

We value your feedback. Please leave a review below:

Have Questions?

Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.

Pure Lab Peptides Logo with Black Letters
0